BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Fibroblast Growth Factors Market Size to worth US$ 6.43 Billion by 2032, Coherent Market Insights

  January 16, 2026

   · 

  1 min read
• Press Releases

  Nasal Irrigation Market Size to Worth US$ 1,695.5 Million by 2032 by Rising Prevalence of Nasal and Respiratory Conditions | Coherent Market Insights

  January 16, 2026

   · 

  1 min read
• 

  Business

  JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer

  Following rusfertide’s triumphant Phase III trial last year, Protagonist must decide how involved to be in future development. Hundreds of millions of dollars are on the line.

  January 16, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

  January 16, 2026

   · 

  8 min read
• Press Releases

  Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

  January 16, 2026

   · 

  8 min read
• 

  Layoffs

  Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug

  Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of the Cambridge, Massachusetts–based biotech’s workforce is being cut while most of the rest are furloughed.

  January 16, 2026

   · 

  2 min read

   · 

  Angela Gabriel
• Press Releases

  Hemostemix Receives FDA Support for Its Basket Protocol Approach

  January 16, 2026

   · 

  8 min read